Effect of device-guided breathing exercises on blood pressure in hypertensive patients with type 2 diabetes mellitus: a randomized controlled trial
Authors:
- Susan J LogtenbergSLSusan J Logtenberg
- Nanne KleefstraNKNanne Kleefstra
- Sebastiaan T HouwelingSHSebastiaan T Houweling
- Klaas H GroenierKGKlaas H Groenier
- Henk J BiloHBHenk J Bilo
- 1 January 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 25 (1) , 241-246
Abstract
In patients with type 2 diabetes mellitus (DM2), it is hard to reach treatment objectives for blood pressure (BP) with classical treatment options. Recently, reducing breathing frequency has been advocated as a method to reduce BP. We examined if an electronic device such as Resperate, by reducing breathing frequency, would lead to BP reduction in a population of patients with DM2 and hypertension. Our secondary objective was to study the effect of this device on quality of life (QOL). A randomized, single-blind, controlled trial was conducted over a period of 8 weeks to evaluate the effect of this therapy on BP and QOL. The control group listened to music and used no other therapeutic device. BP and QOL changes were studied in 30 patients with DM2 and hypertension. There was no significant difference in change in BP between groups; -7.5 [95% confidence interval (CI) -12.7, -2.3]/-1.0 (95% CI -5.5, 3.6) mmHg in the intervention group and -12.2 (95% CI -17.4, -7.0)/-5.5 (95% CI -9.7, -1.4) mmHg in the control group. Whether or not the target breathing frequency of 10 breaths/min was reached did not affect BP. There were no significant changes in QOL. The effects of Resperate on BP and QOL were not significantly different from those found in the control group. Furthermore, 40% of patients did not reach the target breathing frequency, making this device less suitable for clinical practice in patients with DM2.Keywords
This publication has 22 references indexed in Scilit:
- Graded Blood Pressure Reduction in Hypertensive Outpatients Associated With Use of a Device to Assist With Slow BreathingThe Journal of Clinical Hypertension, 2004
- Nonpharmacologic treatment of hypertension by respiratory exercise in the home settingAmerican Journal of Hypertension, 2004
- Nonpharmacologic treatment of resistant hypertensives by Device-Guided slow breathing exercisesAmerican Journal of Hypertension, 2003
- Health-related quality of life deficits associated with varying degrees of disease severity in type 2 diabetesHealth and Quality of Life Outcomes, 2003
- Breathing-control lowers blood pressureJournal of Human Hypertension, 2001
- Treating hypertension with a device that slows and regularises breathing: a randomised, double-blind controlled studyJournal of Human Hypertension, 2001
- Device-guided breathing exercises reduce blood pressure: ambulatory and home measurementsAmerican Journal of Hypertension, 2001
- Autonomic imbalance, hypertension, and cardiovascular riskAmerican Journal of Hypertension, 2000
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complicationsJournal Of Hypertension, 1993